FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms

Early identification of metastatic or recurrent colorectal cancer (CRC) patients who will be sensitive to FOLFOX (5‐FU, leucovorin and oxaliplatin) therapy is very important. We performed microarray meta‐analysis to identify differentially expressed genes (DEGs) between FOLFOX responders and nonresp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Lu, Wei, Fu, Dongliang, Kong, Xiangxing, Huang, Zhiheng, Hwang, Maxwell, Zhu, Yingshuang, Chen, Liubo, Jiang, Kai, Li, Xinlin, Wu, Yihua, Li, Jun, Yuan, Ying, Ding, Kefeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013065/
https://ncbi.nlm.nih.gov/pubmed/31893575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2786
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia